IGMS — IGM Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for IGM Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	366	230	427	338	184
Prepaid Expenses
Total Other Current Assets
Total Current Assets	373	241	438	348	194
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34.8	56.3	73.1	74	71
Other Long Term Assets
Total Assets	409	298	513	423	266
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	17.2	27.8	44.7	42.5	37.6
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	26.8	53.2	226	220	218
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	382	245	287	203	48.2
Total Liabilities & Shareholders' Equity	409	298	513	423	266
Total Common Shares Outstanding